Dr Sharon Ford is the Deputy Director of Nephrology at The Austin Hospital in Melbourne. She has been on council since 2021 and has been involved in the SPARC committee as Deputy Chair from 2019-2022. She is also chair of the TSANZ VCA Advisory Committee. She has completed a laboratory-based PhD at the Centre for Inflammatory Disease at Monash University. She continues her own research as well as overseeing clinical trials at The Austin Hospital having been a Principal Investigator on over 15 commercial and investigator led clinical trials over the last 10 years and a member of S Vincent's Hospital Human Research Ethics Committee for 7 years.

She feels strongly in the need for a revitalised council and executive as well as improved communication with members ensuring increased awareness of the opportunities ANZSN members have to contribute to the society's work and the important education and learning resources and events that ANZSN provides. She will attempt to encourage engagement of all members of the society to ensure all perspectives are considered and the society sustains a balanced focus on research, education and clinical care in all forums and formats in which nephrology care provision occurs now and in the future. She seeks to ensure that broad and diverse representation of society members is provided to council to ensure that the Society's work remains relevant to all its members and those consumers of nephrology clinical care, research and advocacy.

Drew is Clinical Director of the Midland Region Renal Service based at Waikato Hospital. Prior to working at Waikato he was Clinical Lead for Renal Medicine and Electronic Patient Records at NHS Tayside, Dundee, Scotland and prior to this helped establish Hawkes Bay Hospital renal service where he worked as a single handed nephrologist between 2007 and 2011.  

Drew studied medicine at Glasgow University and did his postgraduate training between Glasgow and Dundee, Scotland. He is a member of the National Renal Transplant Service strategic group and has been involved with the ANZSN KPI working group and COVID working group as the NZ representative. His interests include inequity in healthcare, quality improvement and IT. He is currently involved with whole of health system work to reduce health inequalities in the Waikato focussing particularly on improving care pathways and outcomes for Maori patients with kidney disease. He has previously help developed pilot projects to improve primary care management of early stage kidney disease in high risk populations.  

As a member of Council he would like to continue to help the ANZSN focus on quality improvement work and also advocate for the need for equity to placed at the centre of decisions that council make.

A/Prof Wong is a Clinical Academic, Consultant Nephrologist and Director of Renal Research at the Concord Repatriation General Hospital, Sydney. His expert research promotes clinical and pre-clinical research in delaying chronic kidney disease (CKD) progression in glomerular diseases, diabetic nephropathy, and management of complications associated with CKD. He has been central to a number of large-scale randomised controlled trials in a variety of roles, including National Lead, Regional Scientific Advisor, and Steering Committee Member, and holds several leadership and training roles within his institution, at national and international levels. He chair the Education Committee for the Asia Pacific Society of Nephrology, and the Oceania South East Asia Regional Board, International Society of Nephrology, that are central to the shaping global policy for kidney health. A/Prof Wong hopes to achieve the followings through his role as a Council member: 

1. "Kidney health for all" through education, training and research. 
2. Increase opportunity and promote exposure to research- both clinical and basic science.           >To incorporate research into training curriculum and to increase recognition of basic research. 
3. Ongoing work to ensure gender, equity and diversity beyond the Society level.  
4. Implementation of evidence-based medicine through consumer, government and policy maker engagement. Evidence generated through well conducted clinical trials need to accompany by user's engagement to ensure policy change.  
5. To promote regional and international collaboration and networking by forming new bridges and strengthening existing ties with regional and international partners, focusing on low- and middle-income countries. 

A/Prof Lee is a practising staff specialist nephrologist at Westmead Hospital, and Clinical Associate Professor/Academic Lead for the University of Sydney. He received his medical degree through the University of Sydney in 1995, FRACP in 2005 and PhD also through the University of Sydney in 2010. He has worked at Westmead Hospital in various capacities since 2004.

He has worked in education with the Advanced Training Committee (RACP) in Nephrology, the Scientific Program and Education Committee and the Westmead-based Sydney Transplantation and Nephrology Course which is internationally webcast. He is also deputy chair of the ISN Educational Ambassadors committee, member of the ISN Oceania and South East Asia Committee, and mentor for the ISN Mentorship program. He is a Principal Investigator for the Westmead Applied Research Centre which is strongly focussed on implementing research evidence. A/Prof Lee contribute regularly to journal peer review and is current subject editor for the APSN journal Nephrology. He contributes to renal guideline development as Deputy Chair of the steering committee for the peak guideline organisation for Australasian nephrology (CARI, 2021-present). He is very active in clinical governance through his work in medication safety in the Western Sydney Local Health District (WSLHD) (incorporating Westmead Hospital) as Chair of the Drug and Therapeutics Committee (DTC) and deputy chair of the High Cost Medicines Subcommittee (NSW Ministry of Health).

He is keen to contribute in service to the ANZSN Council and believes that his previous work in governance, education and the ISN will support an active role.

Prof Krishnasamy is the Director of Nephrology at the Sunshine Coast University Hospital and Professor for the Faculty of Medicine at the Griffith University with a strong focus on community engagement and inclusivity for the Society. She continues to serve on several committees for the advancement of kidney care including as immediate past Chair of the Caring of Australians and New Zealanders with Kidney Impairment (CARI) Guidelines Steering Committee, Clinical Trialist at Australasian Kidney Trials Network (AKTN), Haemodialysis Working Group member for the AKTN and ANZDATA Registry. Her research interests span across pragmatic trials, reducing socioeconomic burden, cardiovascular disease burden and bone mineral disorders in patients with kidney disease. She is a proud mum of 3 kids (2 boys and a dog that rules the house). 

Professor Melinda Coughlan is a group leader in the Department of Diabetes within Monash University's Central Clinical School, Melbourne, Australia. She studied Biology and Nutrition before obtaining a PhD from The University of Melbourne. Dr Coughlan completed postdoctoral training at the Baker IDI Heart and Diabetes Institute, before moving to Monash University in 2016. 

Her research focuses on gaining an understanding of the molecular mechanisms driving the development of diabetic kidney disease and discovering novel therapeutic targets of disease. She holds an adjunct appointment at the Monash Institute of Pharmaceutical Sciences (MIPS) in Drug Discovery Biology. Dr Coughlan is a recent past member of the ANZSN Research Advisory Committee (2019-2021). She sits on the National Committee for Nutrition of the Australian Academy of Science.

Professor Coughlan's aim is to provide a voice on council for the non-physician, fundamental scientists of the society, and to provide council with a perspective related to basic science research. 

Professor and Director of Nephrology at Monash Medical Centre and Monash University, Clayton, Vic, Australia.  

Peter Kerr completed his undergraduate medicine at Monash University in Melbourne [1980] and completed Nephrology training in Melbourne predominantly under Prof Bob Atkins (past ISN President).  He went on to complete a laboratory PhD in transplant immunology but then moved more to haemodialysis.  He went on to complete a year studying HD in Montpellier, France.  Since then, he has been actively involved in all aspects of Dialysis, especially haemodialysis. He has been involved in registries (ANZDATA and DOPPS), basic and clinical research, and remains an active clinician in charge of a large multi-faceted Nephrology Unit. 

He is a strong advocate for home based dialytic therapies and is committed to building and sustaining Nephrology in the Asian-Pacific region. He was Editor-in-Chief of the Asian-Pacific journal Nephrology, 2010-8.  He has also been a Council member of the ANZSN, APSN, ISHD and ISN, and was chair of the local organizing committee for the World Congress of Nephrology, in Melbourne, 2019.

Prof Andrew Mallett is a Nephrologist with a special interest in inherited kidney disease and nephrogenetics. After graduating from James Cook University (MBBS, 2006) he completed physician training at Mackay Base Hospital, Royal Brisbane and Women's Hospital and Princess Alexandra Hospital (MMed USyd, 2009; AFRACMA 2011; FRACP 2013; FASN 2016). Prof Mallett has undertaken a Churchill Fellowship and been a recurrent Visiting Fellow at Addenbrooke's Hospital (Cambridge, UK) and the Cambridge Institute for Medical Research (University of Cambridge). He has completed a PhD (UQ, 2016) in nephrogenetics collaborating nationally and internationally, and is co-lead of the state-wide Queensland Conjoint Renal Genetics Service. Prof Mallett is National Director of KidGen and Lead of both the Australian Genomics (AGHA) Renal Genetics & HIDDEN Rare Disease Flagships. He is Director of Clinical Research, Consultant Nephrologist & Professor of Medicine at Townsville University Hospital & JCU, in addition to Clinical Fellow at IMB at UQ.

Prof Mallett is passionate about nephrology in all its forms and endeavours across Australia and New Zealand. As a regionally-based and nationally-focused nephrologist and clinician-researcher, Prof Mallett is a voice from regional and Northern Australia. He brings an absolute commitment to transparent and robust contemporary governance that enables key commitment to nephrology research, education and clinical care. From his background facilitating the introduction of genetic and genomic nephrology in his region, he has had the opportunity to collaborate and work closely with adult and paediatric kidney clinicians and researchers all across Australia and New Zealand, in every state and territory and across urban, regional, rural and remote areas. The opportunities that have come from collaboration and partnership are immense. Prof Mallett believes it is the different experiences and perspectives that we bring and share that give great strength to nephrology across our countries as well as in our own back yards. He aims to support the enrichment of that diversity through serving you as ANZSN members at the ANZSN Council.

Dr Kannaiyan Rabindranath graduated from India in 1997 and moved to the UK soon after for further post-graduate training in medicine. He obtained his renal specialist qualification after completing his registrar training in Oxford. His PhD from University of Aberdeen, Scotland was on the use of systematic reviews for improving outcomes for people with kidney diseases addressing several topics on both management of acute kidney injury as well as chronic kidney disease. He was involved in developing the first National Service Framework (NSF) for renal diseases which set out the blue-print for developing Renal Services in UK in 2005. He collated the evidence base for this framework and was involved in drafting the NSF guidelines. 

Dr Rabindranath moved to New Zealand in 2012 and has been working as Consultant Nephrologist in Waikato Hospital, Hamilton. The renal service covers a very wide area with most of the dialysis population comprised of the indigenous people of Aotearoa living in very rural settings. This has given him a very good exposure to inequities in health care delivery and a sense of commitment to help patients overcome them. He has improved patient care in the service by implementing a telehealth programme which is used extensively in his transplant clinics.  He has taken a keen interest in management and has completed an Associate Fellowship course of the Royal Australasian College of Medical Administrators (AFRACMA) and also the Harvard SQUIL (safety, quality, informatics, leadership) course. He helped set-up the clinical trials and research division within his department and has guided several trainees with their research projects and he has been the national lead for several industry sponsored clinical trials. He is also a member of the Chronic Kidney Disease sub-division of the Australasian Kidney Trials Network. 

Natasha Rogers is Staff Specialist and Head of Transplantation at Westmead Hospital, Professor of Nephrology and Transplantation Medicine at the University of Sydney, and Co-Director of the Centre for Transplant and Renal Research at the Westmead Institute for Medical Research. She also runs a discovery and translational laboratory focusing on mechanisms of kidney injury regulated by matrix protein signalling. She has attracted >$10M in research funding from NHMRC, National Heart Foundation, MRFF and Diabetes Australia. Her team developed normothermic machine perfusion and performed the first machine perfusion-treated kidney transplant in Australia in 2021.

Natasha previously wanted to be a concert pianist but realised there were marginally better career opportunities in Nephrology. She has served ANZSN as Chair of SPARC (2021-3) and joined the Research Advisory Committee in 2024 as a strong advocate for the breadth of scientific research across Nephrology. Natasha is also committed to gender equity and supporting early-and-mid career researchers and will bring enthusiasm to supporting these issues while serving on Council.

Bio coming soon. 

Dr Anna Francis MBBS FRACP CF MMed PhD is a clinician researcher at Queensland Children's Hospital, Australia. She has published widely on long term outcomes for children and adolescents with CKD. In 2017, she received a Churchill Fellowship, travelling to Germany, England and Harvard to explore transition programs to adult care. In 2019 she was appointed as an editorial fellow to Kidney International and became an associate editor for Kidney International Reports in 2021.

ANZSN Executive Officer, Marisa Chilcott

anzsn@nephrology.edu.au

ANZSN Project Officer, Joanna Tsang

policy@nephrology.edu.au

ANZSN Communications & Partnerships, Andrea Doney

communications@nephrology.edu.au    

ANZSN Environmental Sustainability Project Officer, Sally Nicolson

environment@nephrology.edu.au    

ANZSN Administration Officer, Sarah Davies

admin@nephrology.edu.au

ANZSN Administration Officer, Mimi Potts

admin@nephrology.edu.au

ANZSN Project Officer, Kelly Phelan

edu@nephrology.edu.au

1965 - 1966  Professor Brian Emmerson - (Inaugural) 

1966 - 1968  Professor Austin Doyle 

1968 - 1970  Professor James Lawrence 

1970 - 1972  Professor Priscilla Kincaid-Smith 

1972 - 1974  Professor Brian Emmerson 

1974 - 1976  Professor Colin Johnston 

1976 - 1978 Dr Peter Little 

1978 - 1980  Dr Anthony Clarkson 

1980 - 1982  A/Professor Robert Atkins 

1982 - 1984  Dr Lindsay Barratt 

1984 - 1986  Professor Vernon Marshall 

1986 - 1988  Dr Ross Bailey 

1988 - 1990  Dr James Petrie 

1990 - 1992  Professor Trefor Morgan AO 

1992 - 1994  Dr Timothy Mathew 

1994 - 1996  Professor John Stewart AM

1996 - 1998  A/Professor Michael Field 

1998 - 2000  A/Professor Graeme Russ 

2000 - 2002  Dr Brendan Murphy AC

2002 - 2004  Professor David Harris AM 

2004 - 2006  Dr Paul Snelling 

2006 - 2008  Professor Robyn Langham AM

2008 - 2010  Professor Randall Faull 

2010 - 2012  A/Professor Vicki Levidiotis 

2012 - 2014  Professor Rowan Walker 

2014 - 2016  Professor Alan Cass AO 

2016 - 2017  Professor Paolo Ferrari AO

2017 - 2019  Professor Jonathan Craig

2019 - 2021 Professor Neil Boudville

2021 - 2023 Professor David Johnson

2023 - 2025 Professor Rathika Krishnasamy